Ionis director Michael R. Hayden reports acquisition of 20,000 common shares worth $1,059,000

• Ionis Pharmaceuticals director Michael R. Hayden reported spouse-affiliated purchases totaling 20,000 common shares at about $52.94 per share.
• Spouse-linked holdings rose to 24,000 shares held indirectly.
• Hayden reported 54,298 Ionis common shares held directly following the filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ionis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000874015-26-000254), on July 31, 2026, and is solely responsible for the information contained therein.